Drug-labels.com

NRA-Tadalafil: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
2.5 mg, 5 mg, 10 mg, 20 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - NRA-Tadalafil

What the medication is used for:

NRA-TADALAFIL is used for treatment of

  • erectile dysfunction (ED) in men (when a man cannot get, or keep a hard, erect penis suitable for sexual activity).
  • the signs and symptoms of benign prostatic hyperplasia (BPH). These symptoms include a frequent need to urinate, a sensation of not emptying the bladder completely, or painful urination.
  • both ED and the signs and symptoms of BPH.

What it does:

NRA-TADALAFIL belongs to a group of medicines called phosphodiesterase type 5 inhibitors.

Treatment of ED: Following sexual stimulation NRA-TADALAFIL works by helping the blood vessels in your penis to relax, allowing the flow of blood into your penis. This results in improved erectile function.

It is important to note that NRA-TADALAFIL works only with sexual stimulation. NRA-TADALAFIL alone does not increase sexual desire.

Treatment of BPH and ED/BPH: NRA-TADALAFIL works by relaxing muscles in the prostate and bladder, which may reduce BPH symptoms.

When it should not be used:

Do not take NRA-TADALAFIL:

  • If you are taking any medicines that contain nitrates in any form (oral, sublingual [under the tongue], skin-patch, or by inhalation). Similarly, nitrates must never be used by men who take NRA-TADALAFIL. Nitrates are found in many prescription medicines used in the treatment of angina pectoris (chest pain due to heart disease), such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate. If nitrates have previously been prescribed to you, even though you may not have used them, or are unsure, tell your doctor.

If you take NRA-TADALAFIL with any nitrate-containing medicines or any other nitrates (e.g., amyl nitrite “poppers”), your blood pressure could suddenly drop to a life-threatening level. You could get dizzy, faint, or even have a heart attack or stroke.

  • Do not take NRA-TADALAFIL if you have had an allergic reaction in the past to tadalafil or any of the other ingredients in NRA-TADALAFIL listed below.
  • If you have had a previous episode of an eye condition called NAION which causes a sudden decrease or loss of vision in one or both eyes.
  • If you are taking riociguat (ADEMPAS®).

What the medicinal ingredient is:

Tadalafil

What the nonmedicinal ingredients are:

The other ingredients are: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, sorbitan monostearate, magnesium stearate, hypromellose, iron oxide red (in 2.5 mg tablets only), iron oxide yellow, talc, titanium dioxide, and triacetin.

What dosage forms it comes in:

NRA-TADALAFIL (tadalafil) comes as almond shaped (2.5 mg, 5 mg, 10 mg and 20 mg) film-coated tablets:

  • 2.5 mg (for Once-a-Day use): Off white to pale yellow coloured, almond shaped, biconvex, film coated tablets, debossed with "FJl" on one side and plain on other side.
  • 5 mg (for Once-a-Day use): Light yellow coloured, almond shaped, biconvex, film coated tablets debossed with "FJ2" on one side and plain on other side.
  • 10 mg (for On-Demand dosing): Yellow coloured, almond shaped, biconvex, film coated tablets, debossed with "FJ3"on one side and plain on other side.

ABOUT THIS MEDICATION

  • 20 mg (for On-Demand dosing): Yellow coloured, almond shaped, biconvex, film coated tablets, debossed with "FJ4" on one side and plain on other side.

The active substance is tadalafil. Each tablet of NRA-TADALAFIL contains 2.5 mg, 5 mg, 10 mg or 20 mg of tadalafil.

Before taking NRA-TADALAFIL talk to your doctor if you:

have or had any of the following conditions:

  • Heart disease or previously had a heart attack: Sexual activity carries a possible risk to patients with heart disease because it puts extra strain on your heart. Before you start any treatment for erectile dysfunction, ask your doctor if your heart is healthy enough to handle the extra strain of having sex. If you have chest pains, dizziness or nausea during sex, stop exerting yourself and tell your doctor you have had this problem.

    • Stroke.
    • Low blood pressure or uncontrolled high blood pressure.
    • Liver or kidney problem.
    • Sickle cell anemia (an abnormality of red blood cells), multiple myeloma (cancer of the bone marrow), or leukemia (cancer of the blood cells).
    • Peptic ulcer or other bleeding disorders.
    • Deformation of the penis.
    • Ever had severe loss of vision, including a condition called Non-Arteritic Ischemic Optic Neuropathy (NAION). The specific type of vision decrease or loss known as NAION has been reported rarely after the intake of tadalafil or other PDE5 inhibitors. Vision decrease or loss may be partial or complete, in one or very occasionally in both eyes. While in some cases the condition may improve over time, it can also be irreversible. If you are taking NRA-TADALAFIL and experience temporary or permanent loss or change in vision, stop taking NRA-TADALAFIL and immediately call your doctor.
    • Hearing problems: Sudden decrease or loss of hearing has been reported with the use of PDE5 inhibitors, including tadalafil, although it is not known if it is due to drug or other factors.
    • Lactose or milk sugar intolerance. NRA-TADALAFIL contains a small amount of lactose (about 250 mg).

      NRA-TADALAFIL is not recommended to be used in combination with alpha blockers if you have symptoms of BPH.

      NRA-TADALAFIL does not protect against sexually transmitted diseases including HIV/ AIDS.

      Long-term studies have shown that tadalafil therapy may decrease sperm concentration in some men. The effect on fertility in men is unknown.

      NRA-TADALAFIL is not intended for use by women or by children under 18 years of age.

      When tadalafil is used for the treatment of erectile dysfunction, diarrhea was reported more frequently in patients 65 years of age and older (2.5% of patients).

      Only your doctor can decide if NRA-TADALAFIL is right for you. If you have ED, you will need to have a physical examination to diagnose your erectile dysfunction and to find out if you can take NRA-TADALAFIL alone or with your other medicines. If you have urinary problems, you will need to have a physical examination to diagnose your BPH and not a more serious condition such as prostate cancer.

      Tell your doctor or pharmacist if you are taking or have recently taken any other medicine, including the medicine you can buy without prescription and natural health products.

      Drugs that may interact with NRA-TADALAFIL include:

      • nitrates (see previous section)
      • rifampin (an antibacterial product used against tuberculosis)
      • ketoconazole or itraconazole (used against fungal infections)
      • erythromycin (an antibacterial product)
      • protease inhibitors such as ritonavir and saquinavir (HIV treatments)

You should not use NRA-TADALAFIL together with any other treatments for erectile dysfunction or PDE5 inhibitors for treatment of pulmonary arterial hypertension (PAH), such as ADCIRCA® (tadalafil) or REVATIO® (sildenafil).

Tell your doctor if you are taking:

  • medicines to treat high blood pressure
  • alpha-blockers (such as doxazosin) for the treatment of prostate problems.

WARNINGS AND PRECAUTIONS

INTERACTIONS WITH THIS MEDICATION

The combination of these medicines with NRA-TADALAFIL may add to the blood-pressure-lowering effect of these drugs.

This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours.

How To Take NRA-TADALAFIL:

Always take NRA-TADALAFIL exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are unsure. Do not take a higher dose than the one which your doctor prescribed for you.

NRA-TADALAFIL tablets are for oral use. Swallow the tablet whole, with some water.

You may take NRA-TADALAFIL with or without food.

Alcohol consumption may decrease the ability to attain an erection and may also temporarily decrease blood pressure.

There are two different ways of taking NRA-TADALAFIL tablets to treat ED: a 20 mg On-Demand dose taken as needed, or a lower 5 mg daily dose. It may take up to up 5 days for NRA-TADALAFIL Once-a-Day to reach steady blood levels.

For patients with ED:

  • Try sex at different times to find out what works best for you and your partner.
  • NRA-TADALAFIL works only if you are sexually stimulated.
  • If you don't get the results you expect ― talk to your doctor or pharmacist.

NRA-TADALAFIL for “On-Demand” Dosing: The recommended dose is one tablet (20 mg) before sexual activity, as needed. You should NOT take more than the prescribed dose of one NRA-TADALAFIL 10 mg or 20 mg tablet per day. The 10 mg and 20 mg doses are not recommended for continuous daily use.

You can engage in sexual activity within 30 minutes of taking the tablet and up to 36 hours later. The amount of time NRA-TADALAFIL takes to work varies from person to person.

NRA-TADALAFIL for Once-a-Day Use:

Treatment of ED: Your doctor may recommend that you take one tablet of NRA-TADALAFIL (5 mg or 2.5 mg) Once-a-Day every day, at approximately the same time each day, regardless of when you are planning to have sex.

Treatment of BPH and ED/BPH: Your doctor may recommend that you take one tablet of NRA-TADALAFIL 5 mg Once-a- Day every day, at approximately the same time each day.

Overdose:

If you think you have taken too much NRA-TADALAFIL, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Like all medicines, NRA-TADALAFIL can have some side-effects. These effects are usually mild to moderate in nature.

The most common side effects are headache, indigestion, back pain, muscle aches, nasal congestion, facial flushing, dizziness and high blood pressure.

Uncommon side-effects: swelling of the eyelids, eye pain, conjunctival hyperemia (red eyes) and allergic reactions (including skin rashes).

Rarely, a prolonged and possibly painful erection may occur after taking NRA-TADALAFIL. If you have such an erection which lasts continuously for more than 4 hours, you should contact a doctor immediately. If this is not treated immediately, permanent penile tissue damage and erectile dysfunction may result.

Sudden decrease or loss of vision has occurred rarely after the use of oral erectile dysfunction medications, including tadalafil. People who have previously experienced a type of vision loss called Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) are at an increased risk of reoccurrence of NAION. If you experience reduction or loss of vision in one or both eyes, stop taking NRA-TADALAFIL and immediately call your doctor.

If you take NRA-TADALAFIL and have chest pain during or after sexual activity, DO NOT use nitrates, and seek immediate medical assistance.

If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

PROPER USE OF THIS MEDICATION

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect
Talk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Common✓
headache
indigestion✓
back pain✓
muscle aches✓
nasal congestion✓
facial flushing✓
Uncommon✓
✓
Swelling of eyelids
eye pain✓
red eyes✓
dizziness✓
allergic reaction
Rare
✓
prolonged erection
chest pain✓
vision loss✓
hearing loss✓
transient amnesia✓

This is not a complete list of side effects. For any unexpected effects while taking NRA-TADALAFIL, contact your doctor or pharmacist.

STORING NRA-TADALAFIL TABLETS

Keep out of the reach and sight of children.

Store your tablets at 15 to 30°C.

Store in the original package.

Do not use after the expiry date stated on the bottles, carton and blister.

If you want more information about NRA-TADALAFIL:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); or by calling the sponsor Nora Pharma Inc. at

    1-877-352-7314.

Nora Pharma Inc.

40 rue Prince-Arthur, Suite 310

Saint-Lambert, Quebec J4P 1X2

Canada

Last Prepared: October 4, 2021

REPORTING SIDE EFFECTS

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

HOW TO STORE IT

MORE INFORMATION

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02520923

Revision date stated in the text: October 4, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for NRA-Tadalafil

Rx or OTC
Prescription (Rx)?
DIN 02520923, 02520931, 02520958, 02520966
Schedule(s) PRESCRIPTION
Active ingredient(s) Tadalafil
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BE Drugs used in erectile dysfunction
          1. G04BE08 Tadalafil
Company NORA PHARMA INC
Strengths and forms
DIN Strength Dosage form(s) Current status
02520923 2.5 MG Tablet Approved October 8, 2021
02520931 5 MG Tablet Marketed October 13, 2022
02520958 10 MG Tablet Approved October 8, 2021
02520966 20 MG Tablet Marketed October 13, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.